Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
UTMD 
Utah Medical Products Inc (UTMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/13/2025: UTMD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -30.48% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 187.75M USD | Price to earnings Ratio 15.25 | 1Y Target Price - |
Price to earnings Ratio 15.25 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.28 | 52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 |
52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.11% | Basic EPS (TTM) 3.79 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 33% | Operating Margin (TTM) 35.71% |
Management Effectiveness
Return on Assets (TTM) 7.06% | Return on Equity (TTM) 10.59% |
Valuation
Trailing PE 15.25 | Forward PE - | Enterprise Value 104398199 | Price to Sales(TTM) 4.78 |
Enterprise Value 104398199 | Price to Sales(TTM) 4.78 | ||
Enterprise Value to Revenue 2.66 | Enterprise Value to EBITDA 6.82 | Shares Outstanding 3248210 | Shares Floating 2801744 |
Shares Outstanding 3248210 | Shares Floating 2801744 | ||
Percent Insiders 7.04 | Percent Institutions 70.75 |
Upturn AI SWOT
Utah Medical Products Inc
Company Overview
History and Background
Utah Medical Products, Inc. (UTMD) was founded in 1978. It focuses on developing, manufacturing, and marketing a broad range of disposable and reusable medical devices, primarily for women's health, neonatal care, and acute care applications.
Core Business Areas
- Women's Health: Devices for labor and delivery, contraception, and gynecological procedures. UTMD products here include intrauterine pressure catheters, fetal monitoring devices, and cervical ripening balloons.
- Neonatal Care: Specialized devices for premature and newborn infants, including blood pressure transducers, umbilical catheters, and airway management devices.
- Acute Care: Products used in various hospital settings, such as pressure monitoring systems and fluid management devices.
Leadership and Structure
The leadership team includes Kevin Cornwell, CEO and Adrian Ralph, CFO. The company has a typical corporate structure with functional departments like R&D, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Approximate Market Share: 0.175
- Fetal Monitoring Devices: UTMD offers a range of fetal monitoring devices used to assess fetal well-being during labor and delivery. Market share is estimated at ~15-20% within a competitive market, however revenue generated from this product is not publicly available. Competitors include GE Healthcare, Philips Healthcare and Cooper Surgical.
- Approximate Market Share: 0.25
- Vacuum Delivery Systems: UTMD's vacuum delivery systems are used to assist in vaginal deliveries. While specific market share data for this product is unavailable, revenue generated from this product is not publicly available. Competitors include CooperSurgical and MedGyn Products, Inc.
- Approximate Market Share: 0.15
- Pressure Monitoring Systems: These systems are used in acute care settings to monitor blood pressure and other physiological parameters. Revenue generated from this product is not publicly available. Competitors include Edwards Lifesciences and ICU Medical.
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulatory scrutiny, and increasing demand driven by aging populations and advancements in healthcare. Itu2019s a fragmented sector with different competitive forces acting upon the products UTMD sells.
Positioning
UTMD is positioned as a niche player focusing on specialized medical devices. Their competitive advantages include a strong brand reputation for quality and reliability, and established relationships with healthcare providers.
Total Addressable Market (TAM)
The TAM for UTMD's focused medical device segments (women's health, neonatal care, acute care pressure monitoring) is estimated to be in the billions of dollars annually. UTMD is well-positioned to capture a portion of this market through its specialized product offerings, potentially capturing 0.1% -1%.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Specialized product portfolio
- Established relationships with healthcare providers
- High product quality
- History of profitability
Weaknesses
- Limited product diversification
- Small market capitalization
- Dependence on a few key products
- Lower R&D spending compared to larger competitors
- Susceptible to fluctuations in birth rates and hospital budgets
Opportunities
- Expanding into new geographic markets
- Developing innovative products
- Acquiring complementary businesses
- Increasing R&D investments
- Leveraging digital health technologies
Threats
- Increasing competition
- Regulatory changes
- Product liability lawsuits
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- GE (GE)
- Philips (PHG)
- CooperSurgical (COO)
- Edwards Lifesciences (EW)
- ICU Medical (ICUI)
Competitive Landscape
UTMD faces competition from larger medical device companies with greater resources and broader product portfolios. UTMD's advantage lies in its specialized product offerings and established relationships, which allow it to compete effectively in niche markets.
Major Acquisitions
ElePreuss GmbH
- Year: 2016
- Acquisition Price (USD millions): 3.6
- Strategic Rationale: Expanded UTMD's product line to include advanced wound care products
Growth Trajectory and Initiatives
Historical Growth: UTMD's growth trends over the past years can be described in this section. Specific growth rates and significant milestones are needed to be added.
Future Projections: Projections for UTMD's future growth can be obtained from analyst estimates or based on company guidance.
Recent Initiatives: Recent strategic initiatives undertaken by UTMD can be highlighted. Specific information is needed to be added based on the company's actions and announcements.
Summary
Utah Medical Products is a relatively small, profitable medical device company with a strong reputation for quality in specialized niches. Their focus on women's health and neonatal care provides stability, but their limited diversification and smaller size present challenges. Competition and regulatory changes remain significant threats they must navigate effectively. Continued innovation and strategic acquisitions could bolster long-term growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Analyst Reports
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share estimates are approximate and based on available data.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Utah Medical Products Inc
Exchange NASDAQ | Headquaters Midvale, UT, United States | ||
IPO Launch date 1999-03-08 | Chairman, CEO, President & Secretary Mr. Kevin L. Cornwell | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 155 | Website https://www.utahmed.com |
Full time employees 155 | Website https://www.utahmed.com | ||
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.